Bahrt Kenneth
Related Filers (2)
Ownership (19)
4
Tuesday, 2/19/2019
Outlook Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/24/2018
Oncobiologics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/27/2018
Oncobiologics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/26/2017
Oncobiologics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/22/2016
Oncobiologics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/17/2016
Oncobiologics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 5/12/2016
Oncobiologics, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 10/17/2013
SAVIENT PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/1/2013
SAVIENT PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Thursday, 3/7/2013
SAVIENT PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/6/2013
SAVIENT PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Monday, 2/4/2013
SAVIENT PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/6/2012
SAVIENT PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Friday, 8/3/2012
SAVIENT PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Monday, 2/13/2012
SAVIENT PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Friday, 11/18/2011
SAVIENT PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Friday, 9/16/2011
SAVIENT PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
3
Tuesday, 8/2/2011
SAVIENT PHARMACEUTICALS INC: Initial statement of beneficial ownership of securities
4
Tuesday, 8/2/2011
SAVIENT PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities